Cheiljedang Corp.

Ree An Yoo

Young Gi Kim

Yang Je Cho

Je Hak Kim

Hyun Su Kim

Sun Pyo Hong

Dong Eok Lee

Dal Hyun Kim

Wang Don Yoo

Wan Je Park

Nam Joong Lee

Kap Soo Noh

Suk Hoon Ha

The present invention relates to a vaccine prepared from an attenuated Pseudomonas aeruginosa strains which are obtained by isolating Pseudomonas aeruginosa in a pure state according to the Fisher-Devlin immunotype and then repeatedly purifying the isolated strain, particularly CFCPA 10142 (KCCM 10029), CFCPA 20215 (KCCM 10030), CFCPA 30720 (KCCM 10031), CFCPA 40057 (KCCM 10032), CFCPA 50243 (KCCM 10033), CFCPA 60534 (KCCM 10034) and CFCPA 70018 (KCCM 10035) strains. In addition, the present invention relates to a process for preparing the vaccine for immunization against Pseudomonas aeruginosa infection which contains cell wall proteins having molecular weights ranging from 10,000 to 100,000. The cell wall protein component of the attenuated strain is non-pathogenic and safe, and exhibits excellent antibody formation capacity and is useful for preparation of a vaccine and therapeutic agent. The cell wall proteins exhibit an excellent cross-protective efficacy for various Pseudomonas aeruginosa strains and a superior antibody inducing property.

Process for preparing a vaccine against pseudomonas aeruginosa using

Growing community of inventors

Kwachun, South Korea

Ree An Yoo